Loading
institutionsInstitution
University of Pisa / Azienda Ospedaliero-Universitaria Pisana
Italian university and hospital whose endocrinology department, under Rossella Elisei, is one of Europe's largest thyroid cancer centres and led the EXAM trial of cabozantinib.
Also called: Università di PisaAOUPPisa University Hospital
Overview
The University of Pisa and its hospital, the Azienda Ospedaliero-Universitaria Pisana, run one of Europe's largest thyroid disease units. The Endocrinology Unit's thyroid cancer group, led by Rossella Elisei, coordinated EXAM, the phase 3 trial reported in the Journal of Clinical Oncology in 2013 in which cabozantinib lengthened progression-free survival in progressive medullary thyroid cancer, and studies the prognostic value of RET mutations and calcitonin doubling time.
Location
Pisa, IT
Type
university
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#651 · 4 points (0 Newsweek + 0 NCI + 4 from 2 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to University of Pisa, including child institutions. 780 works · 10,561 citations · 72% open access · 12% clinical trials · 2% reviews.
Oncology works per year
1412022
1812023
1922024
1472025
1192026
Most works
- Chiara Cremolini154 works
- Ugo Boggi99 works
- Sara Lonardi85 works
- Filippo Pietrantonio68 works
- Emanuele F. Kauffmann58 works
- Luca Morelli55 works
- Francesca Bergamo53 works
- Gianluca Masi52 works
- Carlotta Antoniotti50 works
- Niccolò Napoli49 works
Most cited
- Thyroid cancer
- Endocrinology
- RET-driven cancers
Similar pages
- Key paperEXAM: cabozantinib in progressive medullary thyroid cancer
Shares Rossella Elisei, Medullary thyroid cancer.
- TrialEXAM
Shares Rossella Elisei, Medullary thyroid cancer, Thyroid cancer.
- TrialA Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer a
Shares Medullary thyroid cancer, Thyroid cancer.
- PersonJulien Hadoux
Shares Medullary thyroid cancer, Thyroid cancer.
- PersonVivek Subbiah
Shares Medullary thyroid cancer, Thyroid cancer.
- PersonSamuel A. Wells Jr.
Shares Medullary thyroid cancer, Thyroid cancer.
- TrialZETA
Shares Medullary thyroid cancer, Thyroid cancer.
- TrialA Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRET
Shares Medullary thyroid cancer, Thyroid cancer.